Stopping Statins After Age 75

What Did the Study Find About Stopping Statins After Age 75?

The findings reported by STAT News address an important evidence gap: whether preventive statin treatment must always continue in people older than 75 who have a low likelihood of heart attack or stroke. Researchers reportedly found no increase in mortality after treatment was stopped in this selected population, although that outcome alone cannot establish that discontinuation is safe for every older patient.

Mortality is only one measure of benefit and harm. A complete assessment should also examine nonfatal heart attacks, ischemic strokes, disability, adverse effects, quality of life and the length of follow-up. The result should therefore be interpreted alongside the full study methods rather than as a general recommendation to stop statins at a particular birthday.

Who Should Not Stop a Statin Without Medical Advice?

The reported finding concerns low-risk older adults and should not be extended automatically to people who have experienced a heart attack, ischemic stroke or other atherosclerotic cardiovascular disease. Statins have well-established secondary-prevention benefits because lowering LDL cholesterol reduces the likelihood of future major vascular events.

Diabetes, chronic kidney disease, markedly elevated LDL cholesterol, smoking, high blood pressure and evidence of arterial plaque may also change the balance of benefit. Stopping treatment allows LDL cholesterol to rise toward its untreated level, so clinicians may recommend follow-up testing and cardiovascular risk reassessment if deprescribing is considered.

How Should Older Adults Decide Whether to Continue Statins?

Guidelines emphasize individualized decision-making for adults older than 75 because randomized primary-prevention evidence is less extensive in this age group. The US Preventive Services Task Force has concluded that evidence is insufficient to determine the balance of benefits and harms of starting a statin for primary prevention in adults aged 76 or older; this is not the same as recommending that an existing prescription be stopped.

A medication review can clarify why the statin was prescribed, whether previous cardiovascular disease is present and whether side effects or drug interactions are affecting daily life. When uncertainty remains, clinicians may discuss LDL levels, overall health, treatment goals and sometimes coronary artery calcium testing before reaching a shared decision.